5-METHYL-2-PYRIDIN-4-YLMETHYL-2H-PYRAZOL-3-YLAMINE
- $378 - $874
- Product name: 5-METHYL-2-PYRIDIN-4-YLMETHYL-2H-PYRAZOL-3-YLAMINE
- CAS: 30154-18-8
- MF: C10H12N4
- MW: 188.23
- EINECS:
- MDL Number:MFCD07186470
- Synonyms:TIMTEC-BB SBB010778;ASINEX-REAG BAS 11771473;5-METHYL-2-PYRIDIN-4-YLMETHYL-2H-PYRAZOL-3-YLAMINE;3-Methyl-1-(4-pyridinylmethyl)-1H-pyrazol-5-amine;1H-Pyrazol-5-amine, 3-methyl-1-(4-pyridinylmethyl)-
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAK Scientific
- Product number9504AD
- Product description5-Methyl-2-pyridin-4-ylmethyl-2H-pyrazol-3-ylamine
- Packaging1g
- Price$560
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0033666
- Product description5-METHYL-2-PYRIDIN-4-YLMETHYL-2H-PYRAZOL-3-YLAMINE 95.00%
- Packaging500MG
- Price$777.32
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11150974
- Product description3-Methyl-1-(pyridin-4-ylmethyl)-1H-pyrazol-5-amine 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number019429
- Product description5-Methyl-2-pyridin-4-ylmethyl-2H-pyrazol-3-ylamine
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 9504AD | 5-Methyl-2-pyridin-4-ylmethyl-2H-pyrazol-3-ylamine | 1g | $560 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0033666 | 5-METHYL-2-PYRIDIN-4-YLMETHYL-2H-PYRAZOL-3-YLAMINE 95.00% | 500MG | $777.32 | 2021-12-16 | Buy |
Crysdot | CD11150974 | 3-Methyl-1-(pyridin-4-ylmethyl)-1H-pyrazol-5-amine 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 019429 | 5-Methyl-2-pyridin-4-ylmethyl-2H-pyrazol-3-ylamine | 1g | $378 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|